Imaging Significantly Underestimates the Size of DCIS Tumors
By MedImaging International staff writers Posted on 15 Apr 2021 |
Image: Imaging can underestimate the actual size of a breast tumor (Photo courtesy of Getty Images)
A new study suggests that pre-operative imaging of high-volume ductal carcinoma in situ (DCIS) lesion size is inaccurate.
Researchers at the University of British Columbia (UBC; Vancouver, Canada), Western University (UWO; London, Canada), and Mount Saint Joseph Hospital (Vancouver, Canada) undertook a retrospective review of clinicopathologic data of patients treated for DCIS with breast conserving surgery (BCS) between 2012 and 2018. Mammographic and sonographic lesion sizes were compared with final pathology sizes.
The results showed that for 152 lesions visible on mammography, mean size on imaging was significantly smaller when compared to final pathology (2.3 centimeters versus 3.6 centimeters, respectively); the mean difference of 1.3 cm was a significant underestimation, with a correlation coefficient of 0.367. For the 48 lesions visible on ultrasound, the radiologic size was significantly smaller than pathologic size (1.7 centimeters versus 4.1 centimeters, respectively), but degree of underestimation was not significantly correlated. The study was published on March 23, 2021, in The American Journal of Surgery.
“Imaging size of DCIS tumors assessed by both mammography and ultrasound were significantly smaller when compared with their final size on pathology,” concluded lead author Rachel Liu, MD, of UWO, and colleagues. “Increase in the degree of underestimation by mammography was noted as the histological tumor size increased. This must be taken into consideration during surgical planning for maximizing the success of breast conserving surgery and minimizing return to the operating room.”
DCIS is the most common type of non-invasive breast cancer, in which the abnormal cells are contained inside the milk ducts. If DCIS is not treated, it may eventually develop into invasive breast cancer, which can spread outside the ducts into the breast tissue and then possibly to other parts of the body. Since DCIS cannot usually be felt as a breast lump or other breast change, most cases are diagnosed following routine screening with mammograms or ultrasound, appearing as micro-calcifications.
Related Links:
University of British Columbia
Western University
Mount Saint Joseph Hospital
Researchers at the University of British Columbia (UBC; Vancouver, Canada), Western University (UWO; London, Canada), and Mount Saint Joseph Hospital (Vancouver, Canada) undertook a retrospective review of clinicopathologic data of patients treated for DCIS with breast conserving surgery (BCS) between 2012 and 2018. Mammographic and sonographic lesion sizes were compared with final pathology sizes.
The results showed that for 152 lesions visible on mammography, mean size on imaging was significantly smaller when compared to final pathology (2.3 centimeters versus 3.6 centimeters, respectively); the mean difference of 1.3 cm was a significant underestimation, with a correlation coefficient of 0.367. For the 48 lesions visible on ultrasound, the radiologic size was significantly smaller than pathologic size (1.7 centimeters versus 4.1 centimeters, respectively), but degree of underestimation was not significantly correlated. The study was published on March 23, 2021, in The American Journal of Surgery.
“Imaging size of DCIS tumors assessed by both mammography and ultrasound were significantly smaller when compared with their final size on pathology,” concluded lead author Rachel Liu, MD, of UWO, and colleagues. “Increase in the degree of underestimation by mammography was noted as the histological tumor size increased. This must be taken into consideration during surgical planning for maximizing the success of breast conserving surgery and minimizing return to the operating room.”
DCIS is the most common type of non-invasive breast cancer, in which the abnormal cells are contained inside the milk ducts. If DCIS is not treated, it may eventually develop into invasive breast cancer, which can spread outside the ducts into the breast tissue and then possibly to other parts of the body. Since DCIS cannot usually be felt as a breast lump or other breast change, most cases are diagnosed following routine screening with mammograms or ultrasound, appearing as micro-calcifications.
Related Links:
University of British Columbia
Western University
Mount Saint Joseph Hospital
Latest General/Advanced Imaging News
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques
- AI Model Draws Maps to Accurately Identify Tumors and Diseases in Medical Images